*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C512 - Malignant neoplasm of clitoris - as a primary diagnosis code | C512 - Malignant neoplasm of clitoris - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 3.49 | |
| Readmission Rate (%) | 16.36 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 746: VAGINA, CERVIX AND VULVA PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 747: VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 4,573 | |
| Total Hospitalizations with ICD C512 - Malignant neoplasm of clitoris | 35 | |
| DRG Share of Total Hospitalizations | 0.01 | |
| % of Total ICD C512 - Malignant neoplasm of clitoris in DRG | 43.21 | |
| Avg LOS at DRG | 4.96 | |
| Avg LOS with ICD C512 - Malignant neoplasm of clitoris | 3.2 | |
| Readmission Rate at DRG | 17.45 | |
| Readmission Rate with ICD C512 - Malignant neoplasm of clitoris | NA | |
| Unplanned Readmission Rate at DRG | 11.09 | |
| Unplanned Readmission Rate with ICD C512 - Malignant neoplasm of clitoris | NA | |
| Total Medicare payments at DRG | $49,105,959 | |
| Total Medicare payments with ICD C512 - Malignant neoplasm of clitoris | $355,548 | |
| Total Medicare payment per Day at DRG | $2,165 | |
| Total Medicare payment per Day with ICD C512 - Malignant neoplasm of clitoris | $3,175 | |
| Total Medicare payment per Hospitalization at DRG | $10,738 | |
| Total Medicare payment per Hospitalization with ICD C512 - Malignant neoplasm of clitoris | $10,159 | |
| Total Medicare Charges at DRG | $271,940,111 | |
| Total Medicare Charges with ICD C512 - Malignant neoplasm of clitoris | $1,571,757 | |
| Avg Charges at DRG | $59,466 | |
| Avg Charges with ICD C512 - Malignant neoplasm of clitoris | $44,907 | |
| Mortality Rate at DRG | 0.55 | |
| Mortality Rate with ICD C512 - Malignant neoplasm of clitoris | NA | |
| SNF Discharge Rate at DRG | 15.83 | |
| SNF Discharge Rate with ICD C512 - Malignant neoplasm of clitoris | NA | |
| Home Discharge Rate at DRG | 54.12 | |
| Home Discharge Rate with ICD C512 - Malignant neoplasm of clitoris | 51.43 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 747: VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 746: VAGINA, CERVIX AND VULVA PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 5,216 | |
| Total Hospitalizations with ICD C512 - Malignant neoplasm of clitoris | 41 | |
| DRG Share of Total Hospitalizations | 0.02 | |
| % of Total ICD C512 - Malignant neoplasm of clitoris in DRG | 36.28 | |
| Avg LOS at DRG | 1.8 | |
| Avg LOS with ICD C512 - Malignant neoplasm of clitoris | 1.78 | |
| Readmission Rate at DRG | 6.99 | |
| Readmission Rate with ICD C512 - Malignant neoplasm of clitoris | NA | |
| Unplanned Readmission Rate at DRG | 4.34 | |
| Unplanned Readmission Rate with ICD C512 - Malignant neoplasm of clitoris | NA | |
| Total Medicare payments at DRG | $29,263,906 | |
| Total Medicare payments with ICD C512 - Malignant neoplasm of clitoris | $276,168 | |
| Total Medicare payment per Day at DRG | $3,119 | |
| Total Medicare payment per Day with ICD C512 - Malignant neoplasm of clitoris | $3,783 | |
| Total Medicare payment per Hospitalization at DRG | $5,610 | |
| Total Medicare payment per Hospitalization with ICD C512 - Malignant neoplasm of clitoris | $6,736 | |
| Total Medicare Charges at DRG | $184,533,401 | |
| Total Medicare Charges with ICD C512 - Malignant neoplasm of clitoris | $1,277,548 | |
| Avg Charges at DRG | $35,378 | |
| Avg Charges with ICD C512 - Malignant neoplasm of clitoris | $31,160 | |
| Mortality Rate at DRG | NA | |
| Mortality Rate with ICD C512 - Malignant neoplasm of clitoris | NA | |
| SNF Discharge Rate at DRG | 4.47 | |
| SNF Discharge Rate with ICD C512 - Malignant neoplasm of clitoris | NA | |
| Home Discharge Rate at DRG | 83.09 | |
| Home Discharge Rate with ICD C512 - Malignant neoplasm of clitoris | 53.66 |